Articoli
https://www.pharmadoc.it/wp-content/uploads/2020/07/Schermata-2020-07-27-alle-17.27.07.png
1276
2000
rossana
https://www.pharmadoc.it/wp-content/uploads/2020/12/pharmadoc-logo.png
rossana2020-07-27 17:30:002022-05-05 15:53:47Accordo Quadro e confronto competitivo - Il Piemonte dice basta alle clausole correttive "saves all"
https://www.pharmadoc.it/wp-content/uploads/2020/01/emoderivati-copia.jpg
1530
1920
rossana
https://www.pharmadoc.it/wp-content/uploads/2020/12/pharmadoc-logo.png
rossana2020-01-29 11:56:182020-01-29 14:06:41Equivalenza terapeutica col V livello ATC per i Fattori VIII - il CDS per il lotto semplice competitivo
https://www.pharmadoc.it/wp-content/uploads/2019/10/comparison-drugs.jpg
1280
1920
rossana
https://www.pharmadoc.it/wp-content/uploads/2020/12/pharmadoc-logo.png
rossana2019-10-29 15:39:562019-10-29 16:57:43Sostituibilità automatica tra biosimilari – AIFA spinge per la riforma normativa
https://www.pharmadoc.it/wp-content/uploads/2019/04/shutterstock_1061962874.jpg
1060
1600
rossana
https://www.pharmadoc.it/wp-content/uploads/2020/12/pharmadoc-logo.png
rossana2019-04-29 13:07:172019-04-29 13:07:17Gare regionali per l’acquisto di farmaci in equivalenza terapeutica (Determina AIFA n. 818/2018)
https://www.pharmadoc.it/wp-content/uploads/2019/02/Public-Health.jpg
1280
1920
rossana
https://www.pharmadoc.it/wp-content/uploads/2020/12/pharmadoc-logo.png
rossana2019-02-07 13:19:402019-02-07 13:19:40La programmazione AIFA per il 2019. Si prefigura uno “scossone” al sistema-farmaco
https://www.pharmadoc.it/wp-content/uploads/2019/01/Accordo-quadro-garesito.jpg
1280
1920
rossana
https://www.pharmadoc.it/wp-content/uploads/2020/12/pharmadoc-logo.png
rossana2019-01-10 12:04:092019-05-23 15:08:53Gare per biosimilari prevale l’utilizzo dell’accordo quadro. Il caso delle epoetine.
https://www.pharmadoc.it/wp-content/uploads/2019/01/soldiefarmaci.jpg
1111
1920
rossana
https://www.pharmadoc.it/wp-content/uploads/2020/12/pharmadoc-logo.png
rossana2019-01-03 12:39:392019-05-23 15:00:55Gare di appalto: pubblica amministrazione tra discrezionalità ed eccesso di potere. L’applicazione dell’accordo quadro nell’acquisto di farmaci biologici
https://www.pharmadoc.it/wp-content/uploads/2018/09/Sede-Consip-Roma.jpg
3312
4416
rossana
https://www.pharmadoc.it/wp-content/uploads/2020/12/pharmadoc-logo.png
rossana2018-09-28 17:36:082019-05-23 14:49:52Epoetina alfa, beta e zeta di nuovo in un lotto unico